Both in Biotechnology
Kodiak Sciences vs Kymera Therapeutics
Over the past year KOD returned +741.4% and KYMR returned +96.5%; their daily moves had a correlation of 0.18.
KOD +741.4% KYMR +96.5%Growth of $1, one year, split-adjusted
| Metric | KOD | KYMR |
|---|---|---|
| Price | $99.87 | $112.40 |
| Market cap | $6.28B | $9.35B |
| Today | +5.95% | +2.84% |
| 1 month | +203.8% | −3.9% |
| 6 months | +131.7% | +32.2% |
| Year to date | +257.2% | +44.5% |
| 1 year | +590.7% | +99.7% |
| Revenue growth (YoY) | — | +466.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −94.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 89.0× |
| Net cash | $125.9M | $688.6M |
| Dividend yield | — | — |
| Volatility (60d) | 214.5% | 37.5% |
| Short % of float | 31.7% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).